drugset / Trial / NCT02592096

Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol

NCT02592096 ↗

Phase 1 Unknown 32 enrolled Lee's Pharmaceutical Limited
RandomizedParallel-groupOpen-labelTreatment

Summary

To investigate the safety, tolerance, dynamic percolation model of single dose usage pazufloxacin mesilate ear drops for patients with acute suppurative otitis media or chronic suppurative otitis media

Timeline

Start
2015-07
Primary completion
2016-01
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Pazufloxacin Mesilate Unknown 0.1 % Other
Subject Pazufloxacin Mesilate Unknown 0.3 % Other
Subject Pazufloxacin Mesilate Unknown 0.5 % Other
Subject Pazufloxacin Mesilate Unknown 0.3 g Other

Indications